<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR876.html">Part 876
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  876.2050  Prostate lesion documentation system.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identification. A prostate lesion documentation system is a prescription device intended for use in producing an image of the prostate as an aid in documenting prostate abnormalities previously identified during a digital rectal examination. The device uses pressure sensors and image reconstruction software to produce a prostate image that highlights regional differences in intraprostatic tissue elasticity or stiffness. The device is limited to use as a documentation tool and is not intended for diagnostic purposes or for influencing any clinical decisions.</p><p class="depth1"><em>(b)</em> Classification. Class II (special controls). The special controls for this device are:</p><p class="depth2"><em>(1)</em> Non-clinical and clinical performance testing must demonstrate the accuracy and reproducibility of the constructed image.</p><p class="depth2"><em>(2)</em> Appropriate analysis/testing must validate electromagnetic compatibility, electrical safety, thermal safety, and mechanical safety.</p><p class="depth2"><em>(3)</em> Appropriate software verification, validation, and hazard analysis must be performed.</p><p class="depth2"><em>(4)</em> All elements of the device that may contact the patient must be demonstrated to be biocompatible.</p><p class="depth2"><em>(5)</em> Methods and instructions for reprocessing of any reusable components must be properly validated.</p><p class="depth2"><em>(6)</em> The labeling must include specific information needed to ensure proper use of the device.
[80 FR 72900, Nov. 23, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
